Skip to main content
Top
Published in: European Journal of Epidemiology 12/2020

Open Access 01-12-2020 | SARS-CoV-2 | META-ANALYSIS

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

Authors: Andrew T. Levin, William P. Hanage, Nana Owusu-Boaitey, Kensington B. Cochran, Seamus P. Walsh, Gideon Meyerowitz-Katz

Published in: European Journal of Epidemiology | Issue 12/2020

Login to get access

Abstract

Determine age-specific infection fatality rates for COVID-19 to inform public health policies and communications that help protect vulnerable age groups. Studies of COVID-19 prevalence were collected by conducting an online search of published articles, preprints, and government reports that were publicly disseminated prior to 18 September 2020. The systematic review encompassed 113 studies, of which 27 studies (covering 34 geographical locations) satisfied the inclusion criteria and were included in the meta-analysis. Age-specific IFRs were computed using the prevalence data in conjunction with reported fatalities 4 weeks after the midpoint date of the study, reflecting typical lags in fatalities and reporting. Meta-regression procedures in Stata were used to analyze the infection fatality rate (IFR) by age. Our analysis finds a exponential relationship between age and IFR for COVID-19. The estimated age-specific IFR is very low for children and younger adults (e.g., 0.002% at age 10 and 0.01% at age 25) but increases progressively to 0.4% at age 55, 1.4% at age 65, 4.6% at age 75, and 15% at age 85. Moreover, our results indicate that about 90% of the variation in population IFR across geographical locations reflects differences in the age composition of the population and the extent to which relatively vulnerable age groups were exposed to the virus. These results indicate that COVID-19 is hazardous not only for the elderly but also for middle-aged adults, for whom the infection fatality rate is two orders of magnitude greater than the annualized risk of a fatal automobile accident and far more dangerous than seasonal influenza. Moreover, the overall IFR for COVID-19 should not be viewed as a fixed parameter but as intrinsically linked to the age-specific pattern of infections. Consequently, public health measures to mitigate infections in older adults could substantially decrease total deaths.
Appendix
Available only for authorised users
Literature
11.
go back to reference New York City Department of Health. COVID-19 Data. 2020. New York City Department of Health. COVID-19 Data. 2020.
16.
go back to reference United Kingdom Parliament Office. Antibody tests for COVID-19. 2020. United Kingdom Parliament Office. Antibody tests for COVID-19. 2020.
17.
go back to reference Organization for Economic Cooperation and Development. Member countries. 2020. Organization for Economic Cooperation and Development. Member countries. 2020.
19.
go back to reference Public Health England. Sero-surveillance of COVID-19: week 22. 2020. Public Health England. Sero-surveillance of COVID-19: week 22. 2020.
20.
go back to reference United Kingdom Office for National Statistics. Coronavirus (COVID-19) infection survey: characteristics of people testing positive for COVID-19 in England, August 2020. 2020. United Kingdom Office for National Statistics. Coronavirus (COVID-19) infection survey: characteristics of people testing positive for COVID-19 in England, August 2020. 2020.
24.
go back to reference Japan Ministry of Health Labour and Welfare. Updates on COVID-19 in Japan. 2020. Japan Ministry of Health Labour and Welfare. Updates on COVID-19 in Japan. 2020.
28.
go back to reference University of Utah Health. Utah HERO project announces phase one findings. 2020. University of Utah Health. Utah HERO project announces phase one findings. 2020.
31.
go back to reference Korea Center for Disease Control. Updates on COVID-19 in Korea as of July 9. 2020. Korea Center for Disease Control. Updates on COVID-19 in Korea as of July 9. 2020.
38.
go back to reference U.S. Center for Disease Control and Prevention. COVID-19 pandemic planning scenarios. 2020. U.S. Center for Disease Control and Prevention. COVID-19 pandemic planning scenarios. 2020.
39.
go back to reference Harbord RM, Higgins JPT. Meta-regression in Stata. Stata J. 2008;8(4):493–519.CrossRef Harbord RM, Higgins JPT. Meta-regression in Stata. Stata J. 2008;8(4):493–519.CrossRef
42.
go back to reference Czech Ministry of Health. Collective immunity study SARS-CoV-2: Czech prevalence. 2020. Czech Ministry of Health. Collective immunity study SARS-CoV-2: Czech prevalence. 2020.
43.
go back to reference Denmark State Blood Institute. Notat: Nye foreløbige resultater fra den repræsentative seroprævalensundersøgelse af COVID-19. 2020. Denmark State Blood Institute. Notat: Nye foreløbige resultater fra den repræsentative seroprævalensundersøgelse af COVID-19. 2020.
45.
go back to reference Jersey Health & Community Services. Prevalence of antibodies: community survey round 2. 2020. Jersey Health & Community Services. Prevalence of antibodies: community survey round 2. 2020.
51.
go back to reference Norrbotten Region. Forekomst av antikroppar mot covid-19—Norrbottens befolkning maj 2020. 2020. Norrbotten Region. Forekomst av antikroppar mot covid-19—Norrbottens befolkning maj 2020. 2020.
52.
go back to reference Norway Public Health Institute. Truleg berre ein liten andel av befolkninga som har vore smitta av koronavirus. 2020. Norway Public Health Institute. Truleg berre ein liten andel av befolkninga som har vore smitta av koronavirus. 2020.
53.
go back to reference Oklahoma State Department of Health. Weekly epidemiology and surveillance report. 2020. Oklahoma State Department of Health. Weekly epidemiology and surveillance report. 2020.
54.
go back to reference Oregon State University. TRACE results suggest 17% of Hermiston community infected with SARS-CoV-2. 2020. Oregon State University. TRACE results suggest 17% of Hermiston community infected with SARS-CoV-2. 2020.
56.
go back to reference Rhode Island Department of Health. COVID-19 serology testing brief. 2020. Rhode Island Department of Health. COVID-19 serology testing brief. 2020.
57.
go back to reference Riverside County Joint Information Center. Antibody study shows coronavirus spread wider in Riverside County. 2020. Riverside County Joint Information Center. Antibody study shows coronavirus spread wider in Riverside County. 2020.
59.
go back to reference San Miguel County Department of Health & Environment. IgG antibody tests: statistics and demographics. 2020. San Miguel County Department of Health & Environment. IgG antibody tests: statistics and demographics. 2020.
60.
go back to reference Skowronski DM, Sekirov I, Sabaiduc S, et al. Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia. Canada: March-May; 2020. p. 2020. Skowronski DM, Sekirov I, Sabaiduc S, et al. Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia. Canada: March-May; 2020. p. 2020.
61.
go back to reference Slovenia Government Communication Office. First study carried out on herd immunity of the population in the whole territory of Slovenia. 2020. Slovenia Government Communication Office. First study carried out on herd immunity of the population in the whole territory of Slovenia. 2020.
63.
go back to reference Stockholm Region. Lägesrapport om arbetet med det nya coronaviruset. 2020. Stockholm Region. Lägesrapport om arbetet med det nya coronaviruset. 2020.
65.
go back to reference University of Miami. SPARK-C: understanding the burden of COVID-19 in Miami-Dade County through rapid serological testing of a representative random sample. 2020. University of Miami. SPARK-C: understanding the burden of COVID-19 in Miami-Dade County through rapid serological testing of a representative random sample. 2020.
66.
go back to reference Washoe County Health District. Seroprevalence of SARS-CoV-2 specific antibodies among adults in Washoe County, Nevada on June 9–10, 2020. 2020. Washoe County Health District. Seroprevalence of SARS-CoV-2 specific antibodies among adults in Washoe County, Nevada on June 9–10, 2020. 2020.
68.
go back to reference Wells PM, Doores KM, Couvreur S, et al. Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England. 2020. Wells PM, Doores KM, Couvreur S, et al. Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England. 2020.
69.
go back to reference Sweden Public Health Authority. the infection fatality rate of COVID-19 in Stockholm: technical report. 2020. Sweden Public Health Authority. the infection fatality rate of COVID-19 in Stockholm: technical report. 2020.
71.
go back to reference Giustizia News. Coronavirus, l'incubo senza fine di Ariano Irpino: 60 positivi al tampone dopo i test sierologici. May 28. Giustizia News. Coronavirus, l'incubo senza fine di Ariano Irpino: 60 positivi al tampone dopo i test sierologici. May 28.
72.
go back to reference Austria Statistik. COVID-19 prevalence study: a maximum of 0.15% of the population in Austria infected with SARS-CoV-2. 2020. Austria Statistik. COVID-19 prevalence study: a maximum of 0.15% of the population in Austria infected with SARS-CoV-2. 2020.
73.
go back to reference Saltzman J. Study: 1 out of 10 residents in 4 neighborhoods unwittingly had coronavirus. Boston Globe. 2020 May 15. Saltzman J. Study: 1 out of 10 residents in 4 neighborhoods unwittingly had coronavirus. Boston Globe. 2020 May 15.
74.
go back to reference Micolitti A. Caldari Ortona: 12% cittadini sottoposti a test sierologici positivi con anticorpi al Covid 19. Rete8. 2020 June 3. Micolitti A. Caldari Ortona: 12% cittadini sottoposti a test sierologici positivi con anticorpi al Covid 19. Rete8. 2020 June 3.
75.
go back to reference Finland National Institute for Health and Welfare. Weekly report of THL serological population study of the coronavirus epidemic. 2020. Finland National Institute for Health and Welfare. Weekly report of THL serological population study of the coronavirus epidemic. 2020.
77.
go back to reference Times of Israel Staff. Coronavirus : Israël est encore loin de l’immunité de groupe. Times of Israel. 2020 July 23. Times of Israel Staff. Coronavirus : Israël est encore loin de l’immunité de groupe. Times of Israel. 2020 July 23.
79.
go back to reference CBC News. Serology study gives officials first look at spread of COVID-19 through Alberta's population. 2020 July 30. CBC News. Serology study gives officials first look at spread of COVID-19 through Alberta's population. 2020 July 30.
83.
go back to reference University of Louisville School of Medicine. Phase II results of Co-Immunity Project show higher-than-expected rates of exposure to novel coronavirus in Jefferson County. 2020. University of Louisville School of Medicine. Phase II results of Co-Immunity Project show higher-than-expected rates of exposure to novel coronavirus in Jefferson County. 2020.
90.
go back to reference Northeast Texas Public Health Department. Hideaway COVID-19 antibody testing program. 2020. Northeast Texas Public Health Department. Hideaway COVID-19 antibody testing program. 2020.
111.
go back to reference Canadian Blood Services. COVID-19 seroprevalence report—August 19, 2020. 2020. Canadian Blood Services. COVID-19 seroprevalence report—August 19, 2020. 2020.
119.
go back to reference Italy National Institute of Statistics. Primi risultati dell'indagine di sieroprevalenza sul SARS-CoV-2. 2020. Italy National Institute of Statistics. Primi risultati dell'indagine di sieroprevalenza sul SARS-CoV-2. 2020.
122.
go back to reference Netherlands National Institute for Public Health and the Environment. Children and COVID-19. 2020. Netherlands National Institute for Public Health and the Environment. Children and COVID-19. 2020.
123.
go back to reference Portugal National Institute of Health. Relatório de Apresentação dos Resultados Preliminares do Primeiro Inquérito Serológico Nacional COVID-19. 2020. Portugal National Institute of Health. Relatório de Apresentação dos Resultados Preliminares do Primeiro Inquérito Serológico Nacional COVID-19. 2020.
125.
go back to reference Ireland Health Service Executive. Preliminary report of the results of the study to investigate COVID-19 infection in people living in Ireland (SCOPI): a national seroprevalence study, June–July 2020. 2020. Ireland Health Service Executive. Preliminary report of the results of the study to investigate COVID-19 infection in people living in Ireland (SCOPI): a national seroprevalence study, June–July 2020. 2020.
129.
go back to reference Sweden Public Health Authority. Seroprevalence of antibodies following COVID-19 infection in blood samples from outpatient care, interim report 1, updated on June 18 using data thru week 21—Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården, delrapport 1 - uppdaterad 2020-06-18 med data för prover insamlade vecka 21. 2020. Sweden Public Health Authority. Seroprevalence of antibodies following COVID-19 infection in blood samples from outpatient care, interim report 1, updated on June 18 using data thru week 21—Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården, delrapport 1 - uppdaterad 2020-06-18 med data för prover insamlade vecka 21. 2020.
130.
go back to reference Ontario Public Health. COVID-19 seroprevalence in Ontario: March 27, 2020 to June 30, 2020. 2020. Ontario Public Health. COVID-19 seroprevalence in Ontario: March 27, 2020 to June 30, 2020. 2020.
131.
go back to reference Australia Department of Health. Coronavirus (COVID-19) current situation and case numbers. 2020. Australia Department of Health. Coronavirus (COVID-19) current situation and case numbers. 2020.
132.
go back to reference Iceland Directorate of Health. COVID-19 in Iceland—statistics 28 Feb to 14 June 2020. 2020. Iceland Directorate of Health. COVID-19 in Iceland—statistics 28 Feb to 14 June 2020. 2020.
133.
go back to reference Korea Center for Disease Control. Weekly report on the COVID-19 situation in the Republic of Korea. 2020. Korea Center for Disease Control. Weekly report on the COVID-19 situation in the Republic of Korea. 2020.
134.
go back to reference Lithuania Central Registry. Koronaviruso (COVID-19) Lietuvoje statistika. 2020. Lithuania Central Registry. Koronaviruso (COVID-19) Lietuvoje statistika. 2020.
135.
go back to reference New Zealand Ministry of Health. COVID-19 current cases. 2020. New Zealand Ministry of Health. COVID-19 current cases. 2020.
136.
go back to reference United Kingdom BioBank. UK Biobank SARS-CoV-2 serology study weekly report—21 July 2020. 2020. United Kingdom BioBank. UK Biobank SARS-CoV-2 serology study weekly report—21 July 2020. 2020.
139.
go back to reference France Public Health. COVID-19: point épidémiologique du 9 juillet 2020. 2020. France Public Health. COVID-19: point épidémiologique du 9 juillet 2020. 2020.
141.
go back to reference Acemoglu D, Chernozhukov V, Werning I, Whinston M. Optimal targeted lockdowns in a multi-group SIR model. National Bureau of Economic Research Working Paper 27102. 2020. Acemoglu D, Chernozhukov V, Werning I, Whinston M. Optimal targeted lockdowns in a multi-group SIR model. National Bureau of Economic Research Working Paper 27102. 2020.
142.
go back to reference U.S. National Center for Health Statistics. Underlying cause of death, 1999–2018. 2020. U.S. National Center for Health Statistics. Underlying cause of death, 1999–2018. 2020.
143.
go back to reference United Kingdom Office of National Statistics. Mortality statistics—underlying cause, sex and age. 2020. United Kingdom Office of National Statistics. Mortality statistics—underlying cause, sex and age. 2020.
144.
go back to reference World Health Organization. Coronavirus disease (COVID-19): similarities and differences with influenza. 2020. World Health Organization. Coronavirus disease (COVID-19): similarities and differences with influenza. 2020.
149.
go back to reference Ferguson N, Laydon D, Nedjati-Gilani G, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. 2020. Ferguson N, Laydon D, Nedjati-Gilani G, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. 2020.
151.
go back to reference Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates. 2020. Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates. 2020.
153.
go back to reference Ward H, Cooke G, Atchison C. Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. 2020 Ward H, Cooke G, Atchison C. Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. 2020
156.
go back to reference Kang S-J, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–64.CrossRef Kang S-J, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–64.CrossRef
162.
go back to reference Brazil Ministry of Health. COVID-19 no Brasil, obitos acumulados−−Manaus. 2020. Brazil Ministry of Health. COVID-19 no Brasil, obitos acumulados−−Manaus. 2020.
Metadata
Title
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Authors
Andrew T. Levin
William P. Hanage
Nana Owusu-Boaitey
Kensington B. Cochran
Seamus P. Walsh
Gideon Meyerowitz-Katz
Publication date
01-12-2020
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 12/2020
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-020-00698-1

Other articles of this Issue 12/2020

European Journal of Epidemiology 12/2020 Go to the issue